Publications

  • A Path to Faster Growth for Healthcare Companies: Eliminate Complexity

    November 08, 2017 | Bain Brief

    Healthcare manufacturers have long believed that all revenue growth is good. But to increase the top line, many launched new products without addressing legacy versions, entered new categories without a path to leadership and expanded to all corners of the world without sufficient local scale.

  • How to Make Your Drug Launch A Success

    October 23, 2017 | IN VIVO

    The pain is becoming all too common for many pharmaceutical executives. After a decade or more of investment in drug development and clinical trials, a company launches a promising new product only to see sales fall far short of expectations.

  • Why Leading Medtech Companies Are Putting Customers Ahead of Products

    September 07, 2017 | Bain Brief

    The leadership team at a global technology company had to move fast. Its products were losing market share as customers switched to integrated solutions. Worse, clients cited the company’s lack of responsiveness as a main reason for switching.

  • How to Make Your Drug Launch a Success

    September 06, 2017 | Pharmaceuticals | Bain Brief

    Bain research shows successful pharmaceutical companies are overhauling their approach to drug launch—and they do three things right.

  • Finding The Right Path To Category Leadership In Oncology

    June 03, 2017 | IN VIVO

    Oncology drug development is undergoing rapid shifts. Bain research shows companies that seek to lead in specific vertical categories outperform rivals that invest across a broad spectrum of cancer targets.

  • Focus for Higher Returns in Biopharma

    March 22, 2017 | Bain infographic

    For large biopharmaceutical companies, complexity hurts profitability. The best performing companies combine category leadership with portfolio focus.

  • Focus Matters: How Biopharma Can Reward Shareholders

    November 30, 2016 | Bain Brief

    Why do the largest companies struggle to deliver above-average shareholder returns? And more important, what can they do to lift a stubbornly low TSR? The short answer: Avoid complex, wide-ranging portfolios that undermine focus.

  • US Election Bulletin: Implications for Healthcare

    November 10, 2016 | Bain Brief

    The election of a Republican president, combined with Republican control of both houses of Congress, has the potential to reshape the healthcare market landscape.

  • Todd Sangster: Category Leadership in Oncology

    November 09, 2016 | Bain video

    Three strategies for building category leadership and achieving success in the rapidly growing sector of oncology.

  • Nils Behnke: New paths to value creation in pharma

    December 17, 2014 | Bain video

    In this short video, Partner Nils Behnke shares lessons from ten high-performing pharmaceutical companies.